Synthesis and halogenation of 2-methylimidazo[1,2-a]pyridine. Antimicrobial activity of 3-bromo-2-methyl-1Н-imidazo[1,2-a]pyridinium bromide

被引:0
作者
Elena V. Kalita
Dmitry G. Kim
Elizaveta M. Krynina
Vladimir V. Sharutin
Nina M. Shlepotina
Oleg L. Kolesnikov
Yulia S. Shishkova
Margarita V. Peshikova
机构
[1] South Ural State University (National Research University),
[2] Moscow Institute of Physics and Technology (National Research University),undefined
[3] South Ural State Medical University,undefined
[4] Ministry of Health of the Russian Federation,undefined
来源
Chemistry of Heterocyclic Compounds | 2022年 / 58卷
关键词
2-aminopyridine; 3-halo-2-methyl-1; -imidazo[1,2-; ]pyridinium trihalides and halides; 2-methylimidazo[1,2-; ]pyridine; alkylation; antimicrobial activity; halogenation;
D O I
暂无
中图分类号
学科分类号
摘要
Imidazo[1,2-a]pyridine derivatives have been shown to possess a broad range of biological activity. 2-Amino-1-propargylpyridinium and 2-amino-1-(2-bromoallyl)pyridinium bromides, the structures of which were established on the basis of X-ray structural analysis, reacted with sodium methoxide, leading to the formation of 2-methylimidazo[1,2-a]pyridine. 2-Methylimidazo[1,2-a]pyridine further reacted with bromine and iodine, providing 3-halo-2-methyl-1H-imidazo[1,2-a]pyridinium trihalides, the structure of which was confirmed by X-ray structural analysis. 3-Halo-2-methyl-1H-imidazo[1,2-a]pyridinium halides were obtained from the respective trihalides. 3-Bromo- 2-methyl-1H-imidazo[1,2-a]pyridinium bromide showed antimicrobial properties against Staphylococcus aureus at the concentrations of 2700 and 675 μg/ml.
引用
收藏
页码:227 / 234
页数:7
相关论文
共 108 条
[1]  
Suloeva E(1999)undefined Chem. Heterocycl. Compd. 10 1121-undefined
[2]  
Yure M(2008)undefined Tetrahedron Lett. 49 3819-undefined
[3]  
Gudriniece E(2007)undefined Tetrahedron Lett. 48 7263-undefined
[4]  
Bakherad M(2016)undefined Green Chem. 18 4623-undefined
[5]  
Nasr-Isfahani H(2019)undefined Anal. Chim. Acta 1077 243-undefined
[6]  
Keivanloo A(2019)undefined RSC Adv. 9 29856-undefined
[7]  
Doostmohammadi N(2018)undefined RSC Adv. 8 5058-undefined
[8]  
Adib M(2013)undefined J. Med. Chem. 56 9045-undefined
[9]  
Mahdavi M(2020)undefined Synth. Commun. 50 197-undefined
[10]  
Noghania MA(2020)undefined Synth. Commun. 50 710-undefined